Xiaofeng Q. Zeng

Beijing, 100081, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 129 publications

Physiological age estimation model on pediatric panoramic radiographs based on machine learning and deep learning

Physiological age estimation model on pediatric panoramic radiographs based on machine learning and deep learning

Journal: Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology
Published: April 29, 2026

Comparative Value of Traditional versus Novel Immune-Inflammatory Indices in Assessing Disease Activity of Sjögren's Disease: A Multicenter Cohort Study.

Comparative Value of Traditional versus Novel Immune-Inflammatory Indices in Assessing Disease Activity of Sjögren's Disease: A Multicenter Cohort Study.

Journal: Clinical rheumatology
Published: April 09, 2026

Anti-CD19 chimeric antigen receptor T cells in Evans syndrome of systemic lupus erythematosus.

Anti-CD19 chimeric antigen receptor T cells in Evans syndrome of systemic lupus erythematosus.

Journal: Annals of hematology
Published: March 09, 2026

Prognostic value of antiphospholipid antibodies in pregnancy outcomes in systemic lupus erythematosus.

Prognostic value of antiphospholipid antibodies in pregnancy outcomes in systemic lupus erythematosus.

Journal: RMD open
Published: February 24, 2026

Exploring clinical subtypes of Chinese patients with psoriatic arthritis based on cluster analysis: a national registry study (CREPAR V).

Exploring clinical subtypes of Chinese patients with psoriatic arthritis based on cluster analysis: a national registry study (CREPAR V).

Journal: Clinical rheumatology
Published: December 09, 2025

Xeligekimab, an Interleukin-17A Antagonist for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 48-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study.

Xeligekimab, an Interleukin-17A Antagonist for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 48-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: October 28, 2025

Low-to-moderate dose glucocorticoids in primary Sjögren's syndrome patients on hydroxychloroquine/iguratimod therapy: a target trial emulation study.

Low-to-moderate dose glucocorticoids in primary Sjögren's syndrome patients on hydroxychloroquine/iguratimod therapy: a target trial emulation study.

Journal: Clinical rheumatology
Published: October 27, 2025

MSC-derived microvesicles inhibit the progression of arthritis in a murine model of preclinical rheumatoid arthritis.

MSC-derived microvesicles inhibit the progression of arthritis in a murine model of preclinical rheumatoid arthritis.

Journal: Frontiers in immunology
Published: October 12, 2025

Anti-CD19 CAR T cell therapy for refractory SLE-ITP.

Anti-CD19 CAR T cell therapy for refractory SLE-ITP.

Journal: Med (New York, N.Y.)
Published: September 22, 2025

Interferon-Driven Tryptophan Metabolism Links Inflammation and Mental Health in Juvenile Dermatomyositis.

Interferon-Driven Tryptophan Metabolism Links Inflammation and Mental Health in Juvenile Dermatomyositis.

Journal: Inflammation
Published: August 08, 2025

Risk factors for disease progression in primary Sjögren's syndrome patients with low disease activity: a multicenter registry-based cohort study.

Risk factors for disease progression in primary Sjögren's syndrome patients with low disease activity: a multicenter registry-based cohort study.

Journal: Clinical rheumatology
Published: August 05, 2025

Anti-CD38 monoclonal antibody CM313 for systemic lupus erythematosus: a randomized, double-blind, placebo-controlled phase Ib/IIa trial.

Anti-CD38 monoclonal antibody CM313 for systemic lupus erythematosus: a randomized, double-blind, placebo-controlled phase Ib/IIa trial.

Journal: Signal transduction and targeted therapy
Published: May 13, 2025
Showing 1-12 of 129

Last Updated: 09/26/2026